Products with Vasoprotective bioactivity

Cat.No. Product Name
BCN3260 Chebulic acid
1. Chebulic acid at both doses (25 and 50 mg/kg) improves biochemical alterations caused by renal ischemia in diabetic rats. 2. Chebulic acid has effects against the progression of AGE-induced endothelial cell dysfunction, may constitute a promising intervention agent against diabetic vascular complications. 3. Chebulic acid significantly reduced the tert-butyl hydroperoxide (t-BHP)-induced cell cytotoxicity, intracellular reactive oxygen species level, and the ratio of GSSH, oxidized form of glutathione (GSH) to the over total GSH (GSH + GSSG) (4.42%) as compared to that with t-BHP alone (8.33%).
BCN3560 Zedoarondiol
1. Zedoarondiol has anti-inflammatory activity, inhibits iNOS, COX-2, and pro-inflammatory cytokine expressions by suppressing the phosphorylations of IKK and MAPKs, and by subsequently inactivating the NF-kappaB pathway. 2. Zedoarondiol dose-dependently inhibits LPS-stimulated nitric oxide (NO), prostaglandin E(2) (PGE(2)), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) productions in RAW 264.7 macrophage and in mouse peritoneal macrophage cells.
BCN3812 Parishin B
Parishin B has good neuroprotective effects against brain disorders, it can prevent vascular dementia.
BCN3813 Parishin C
1. Parishin C can prevent vascular dementia. 2. Parishin C has antipsychotic effects, requires activation of 5-HT(1A) receptors.
BCN4212 Dihydroguaiaretic acid
1. Dihydroguaiaretic acid has antioxidative activity, can significantly protect primary cultured neuronal cells against glutamate-induced oxidative stress. 2. Meso-dihydroguaiaretic acid inhibits the cyclooxygenase-2 (COX-2)-dependent phase of prostaglandin D2 (PGD2) generation in bone marrow-derived mast cells (BMMC) (IC50 9.8 μM). 3. Dihydroguaiaretic acid shows an inhibitory effect against the complex formation of the fos-jun dimer and the DNA consensus sequence with an IC50 value of 0.21 micromol, suppresses leukemia, lung cancer and colon cancer in an in vitro bioassay.

Items 11 to 15 of 24 total

     
  1. First
  2.  
  3.  
  4. 1
  5. 2
  6. 3
  7. 4
  8. 5
  9.  
  10.  
  11. Last